Brain homovanillic acid: regional changes following chronic antipsychotic drug administration.
D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001923:Brain Chemistry / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D003024:Clozapine / Q000494:pharmacology; D004361:Drug Tolerance; D005476:Fluphenazine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000032:analysis* / Q000134:cerebrospinal fluid; D008297:Male; D010648:Phenylacetates / Q000032:analysis*; D011817:Rabbits; D013881:Thioridazine / Q000494:pharmacology; D013997:Time Factors
D014150:Antipsychotic Agents; D010648:Phenylacetates; D003024:Clozapine; D006220:Haloperidol; D013881:Thioridazine; D005476:Fluphenazine; D002746:Chlorpromazine; D006719:Homovanillic Acid